- Home
- ATYR vs PNST Comparison
ATYR vs PNST Comparison
Compare ATYR & PNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- PNST
- Stock Information
- Founded
- ATYR 2005
- PNST 2007
- Country
- ATYR United States
- PNST United States
- Employees
- ATYR N/A
- PNST N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- PNST Blank Checks
- Sector
- ATYR Health Care
- PNST Finance
- Exchange
- ATYR Nasdaq
- PNST Nasdaq
- Market Cap
- ATYR 228.1M
- PNST 111.5M
- IPO Year
- ATYR 2015
- PNST N/A
- Fundamental
- Price
- ATYR $3.30
- PNST $0.46
- Analyst Decision
- ATYR Strong Buy
- PNST Strong Buy
- Analyst Count
- ATYR 4
- PNST 3
- Target Price
- ATYR $19.25
- PNST $2.50
- AVG Volume (30 Days)
- ATYR 787.2K
- PNST 176.8K
- Earning Date
- ATYR 11-07-2024
- PNST 11-26-2024
- Dividend Yield
- ATYR N/A
- PNST N/A
- EPS Growth
- ATYR N/A
- PNST N/A
- EPS
- ATYR N/A
- PNST N/A
- Revenue
- ATYR $235,000.00
- PNST $123,579,000.00
- Revenue This Year
- ATYR N/A
- PNST $25.96
- Revenue Next Year
- ATYR $1,200.54
- PNST $19.30
- P/E Ratio
- ATYR N/A
- PNST N/A
- Revenue Growth
- ATYR N/A
- PNST 11.06
- 52 Week Low
- ATYR $1.34
- PNST $0.44
- 52 Week High
- ATYR $3.80
- PNST $16.00
- Technical
- Relative Strength Index (RSI)
- ATYR 52.43
- PNST 33.46
- Support Level
- ATYR $3.05
- PNST $0.44
- Resistance Level
- ATYR $3.26
- PNST $0.93
- Average True Range (ATR)
- ATYR 0.22
- PNST 0.12
- MACD
- ATYR -0.03
- PNST -0.02
- Stochastic Oscillator
- ATYR 30.00
- PNST 4.33
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About PNST Pinstripes Holdings Inc.
Pinstripes Holdings Inc is an experiential dining and entertainment concept combining exceptional Italian-American cuisine with bowling, bocce, and private events. It owns and operates around 17 restaurants in the USA. The company designs and constructs large-format locations that are each 26,000 to 38,000 square feet of interior space, plus additional outdoor patio space that includes outdoor dining, bocce courts, fire-pits, and decorative fountains.